The problem occurs when the intestinal barrier is damaged, due to certain triggers, oxidative stress or inflammation. The gates, called tight junctions, between the epithelial cells that make up the intestinal wall open up. This means substances that would normally stay in the intestine or be excreted by the body, can travel into the inner layer of our intestinal wall and our blood stream. The intestine is more permeable, it is 'leaky', and bigger particles can fit through.2
This stimulates the immune system and the release of inflammatory mediators against these substances. These molecules, which are now classed as foreign or dangerous, may be the healthy bacteria that normally live in intestines or particles of food normally eaten. This process can trigger more inflammation, allergic responses, further increases in intestinal permeability, changes in nervous system function and opioid type reactions, affecting mood and behavior.3
The gastrointestinal system contains its own nervous system – the enteric nervous system. It is through this system, and a nerve called the vagus nerve, along with endocrine (hormones) and immune pathways, that researchers believe the gut communicates with the brain.
The gastrointestinal enteric nervous system also regulates intestinal permeability.
Therefore, a healthy intestinal wall and a balanced gut microbiota are crucial to maintain the intestinal barrier and reduce the risk of gastrointestinal and neurological conditions.
However, studies testing intestinal permeability in individuals with ASD have had mixed results. This potentially highlights variability within the condition and the need for individual testing and treatment.
A widely used screening test for intestinal permeability is the lactulose-mannitol (L/M) test, while a functional stool test will provide further information on intestinal bacteria levels and environmental health.
One concern with ASD is the effect of opioid peptides (protein fractions) from cow's milk (casein) and gluten. These fractions are supposed to be broken down in a healthy gut environment by digestive enzymes, such as dipeptidyl peptidase IV, but their absorption into the bloodstream may be increased with intestinal permeability.
Opioid peptides can disturb gut function and increase pain and constipation. In the brain, these peptides may be linked to developmental disturbances, learning and interpersonal skill difficulties, and behavioural problems indicative of ASD.
These peptides and intestinal permeability have also been linked to schizophrenia.
All treatments need to be individualised by a qualified healthcare practitioner to each patient according to diagnostic testing, severity, symptom picture and genetic and family history.
Nutritional therapies for intestinal permeability
References
Toh MC, Allen-Vercoe E. The human gut microbiota with reference to autism spectrum disorder: Considering the whole as more than a sum of its parts. Microb Ecol Health Dis. 2015;26:26309.
Rapin JR, Wiernsperger N. Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine. Clinics (São Paulo, Brazil). 2010;65(6):635-43.
Julio-Pieper M, Bravo JA, Aliaga E, et al. Review article: Intestinal barrier dysfunction and central nervous system disorders–a controversial association. Aliment Pharmacol Ther. 2014;40(10):1187-201.
Cryan JF, Dinan TG. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience. 2012;13(10):701-12.
Prindle A, Liu J, Asally M, et al. Ion channels enable electrical communication in bacterial communities. Nature. 2015;527(7576):59-63.
Yano Jessica M, Yu K, Donaldson Gregory P, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell.161(2):264-76.
Wakefield AJ, Puleston JM, Montgomery SM, et al. Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther. 2002;16(4):663-74.
Lister J, Fletcher PJ, Nobrega JN, et al. Behavioral effects of food-derived opioid-like peptides in rodents: Implications for schizophrenia? Pharmacol Biochem Behav. 2015;134:70-8.
Leclercq S, Cani PD, Neyrinck AM, et al. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects. Brain Behav Immun. 2012;26(6):911-8.
Pavlidis P, Bjarnason I. Aspirin induced adverse effects on the small and large intestine. Curr Pharm Des. 2015;21(35):5089-93.
Lerner A, Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev. 2015;14(6):479-89.
Stachowicz-Stencel T, Synakiewicz A, Owczarzak A, et al. Association between intestinal and antioxidant barriers in children with cancer. Acta Biochim Pol. 2012;59(2):237-42.
Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: Consensus on new nomenclature and classification. BMC Med. 2012;10:13.